Warning: The NCBI web site requires JavaScript to function. more...
Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3).
Pillai SK, Wong JK, Barbour JD.
Retrovirology. 2008 Mar 13;5:26.
Related citations
Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z, Zhang W, Chen G, Xu R, Yu XF.
J Mol Biol. 2008 Sep 12;381(4):1000-11. Epub 2008 Jun 28.
Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y, Wang X, York IA, Zheng YH.
J Virol. 2010 Sep;84(17):8561-70. Epub 2010 Jun 30.
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
Izumi T, Shirakawa K, Takaori-Kondo A.
Mini Rev Med Chem. 2008 Mar;8(3):231-8. Review.
HIV-1 Vif, APOBEC, and intrinsic immunity.
Goila-Gaur R, Strebel K.
Retrovirology. 2008 Jun 24;5:51. Review.
Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.
PLoS One. 2008;3(12):e3963. Epub 2008 Dec 17.
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA, Pathak VK.
J Virol. 2007 Aug;81(15):8201-10. Epub 2007 May 23.
Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.
J Virol. 2009 Feb;83(4):1992-2003. Epub 2008 Nov 26.
[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B, Cen S, Jiang JD.
Yao Xue Xue Bao. 2008 Jul;43(7):678-82. Review. Chinese.
APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
Han Y, Wang X, Dang Y, Zheng YH.
PLoS Pathog. 2008 Jul 4;4(7):e1000095.
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK.
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. Epub 2004 Mar 30.
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals.
Fourati S, Malet I, Binka M, Boukobza S, Wirden M, Sayon S, Simon A, Katlama C, Simon V, Calvez V, Marcelin AG.
AIDS. 2010 Sep 24;24(15):2313-21.
Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
Yamashita T, Nomaguchi M, Miyake A, Uchiyama T, Adachi A.
Microbes Infect. 2010 Feb;12(2):166-71. Epub 2009 Nov 26.
APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis.
Sadler HA, Stenglein MD, Harris RS, Mansky LM.
J Virol. 2010 Jul;84(14):7396-404. Epub 2010 May 12.
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.
Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. Review.
Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
Marin M, Golem S, Rose KM, Kozak SL, Kabat D.
J Virol. 2008 Jan;82(2):987-98. Epub 2007 Oct 31.
A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.
Chen G, He Z, Wang T, Xu R, Yu XF.
J Virol. 2009 Sep;83(17):8674-82. Epub 2009 Jun 17.
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM.
J Virol. 2004 Jun;78(11):6073-6.
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes.
Iwabu Y, Kinomoto M, Tatsumi M, Fujita H, Shimura M, Tanaka Y, Ishizaka Y, Nolan D, Mallal S, Sata T, Tokunaga K.
J Biol Chem. 2010 Nov 12;285(46):35350-8. Epub 2010 Sep 10.
Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y, Davis RW, York IA, Zheng YH.
J Virol. 2010 Jun;84(11):5741-50. Epub 2010 Mar 24.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on